Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             58 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis Leurs, C.E.
2019
28 C p. 44-49
artikel
2 Acute leukocytosis during alemtuzumab treatment in patients with active relapsing-remitting multiple sclerosis Iovino, Aniello
2019
28 C p. 98-100
artikel
3 Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review Yoon, Ee Ling
2019
28 C p. 104-108
artikel
4 Altered volume and microstructural integrity of hippocampus in NMOSD Chen, Xiaoya
2019
28 C p. 132-137
artikel
5 Anti-HSV-2 antibody in patients with MS and NMO Etemadifar, Masoud
2019
28 C p. 286-289
artikel
6 A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child Sarigecili, Esra
2019
28 C p. 101-103
artikel
7 A single nucleotide polymorphism in the metabotropic glutamate receptor 7 gene is associated with multiple sclerosis in Iranian population Mazdeh, Mehrdokht
2019
28 C p. 189-192
artikel
8 Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis Giarola, Blake
2019
28 C p. 31-33
artikel
9 Autoimmune inflammatory meningoencephalitis in a patient negative for glial fibrillary acidic protein-specific immunoglobulin G Xie, Longchang
2019
28 C p. 167-171
artikel
10 Autonomic symptom burden can predict disease activity in early multiple sclerosis Krbot Skorić, Magdalena
2019
28 C p. 250-255
artikel
11 Benefit evaluation in multiple sclerosis relapse treatment from the patients’ perspective – Development and validation of a new questionnaire Beckmann, Helen
2019
28 C p. 256-261
artikel
12 Biotinidase deficiency should be considered in individuals thought to have multiple sclerosis and related disorders Wolf, Barry
2019
28 C p. 26-30
artikel
13 Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity Masvekar, Ruturaj
2019
28 C p. 34-43
artikel
14 Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder Zhou, Yifan
2019
28 C p. 213-220
artikel
15 Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: A case report Aoe, Shingo
2019
28 C p. 165-166
artikel
16 Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test) Meca-Lallana, J.E.
2019
28 C p. 50-56
artikel
17 Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report. Arreola-Mora, C.
2019
28 C p. 117-124
artikel
18 Erythema nodosum in a patient with multiple sclerosis on dimethyl fumarate Algahtani, Hussein
2019
28 C p. 155-158
artikel
19 Factors associated with receiving bone mineral density screening among people with multiple sclerosis Bisson, Etienne J.
2019
28 C p. 305-308
artikel
20 First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study Lavandier, Noëlle
2019
28 C p. 309-312
artikel
21 First report of coexistence of MOG-antibody-positive disease and Crohn's disease Philippart, Marie
2019
28 C p. 1-3
artikel
22 Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination Zhou, Ji
2019
28 C p. 4-10
artikel
23 Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease Pedreño, Marta
2019
28 C p. 230-234
artikel
24 Frequency, type, distribution of pain and related factors in persons with multiple sclerosis, Kahraman, Turhan
2019
28 C p. 221-225
artikel
25 Geographic variations of multiple sclerosis in Iran: A population based study Hosseinzadeh, Ali
2019
28 C p. 244-249
artikel
26 Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study Nguyen, Ai-Lan
2019
28 C p. 235-243
artikel
27 Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literature Roddam, Hazel
2019
28 C p. 290-304
artikel
28 In vivo conversion of astrocytes to oligodendrocyte lineage cells in adult mice demyelinated brains by Sox2 Farhangi, Sahar
2019
28 C p. 263-272
artikel
29 Is the ‘MS establishment’ biased; the case for addressing gender inequality in the field of MS? Giovannoni, Gavin
2019
28 C p. 153-154
artikel
30 Letter to the editor on “Multiple sclerosis registries in Europe – An updated mapping survey” published in Multiple Sclerosis and Related Disorder 27 (2019) 171–178 Stefan, Braune
2019
28 C p. 262
artikel
31 Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions Mealy, Maureen A.
2019
28 C p. 64-68
artikel
32 Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis Mohamed, Mohamed Salah
2019
28 C p. 226-229
artikel
33 MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis Wijnands, José M.A.
2019
28 C p. 138-144
artikel
34 Multiple sclerosis and cancer incidence: A Danish nationwide cohort study Nørgaard, M.
2019
28 C p. 81-85
artikel
35 Multiple Sclerosis and Vitamin D – Caviar or a Dog’s Dinner? Hawkes, Chris
2019
28 C p. A1-A2
artikel
36 Multiple sclerosis risk factors contribute to onset heterogeneity Briggs, Farren B.S.
2019
28 C p. 11-16
artikel
37 Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases Codjia, Pekes
2019
28 C p. 109-116
artikel
38 Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases Bibic, Vlad C.
2019
28 C p. 125-128
artikel
39 Neurophysiological, radiological and neuropsychological evaluation of fatigue in multiple sclerosis Chalah, Moussa A.
2019
28 C p. 145-152
artikel
40 Otolaryngological symptoms and multiple sclerosis: A forgotten and underestimated relationship Di Stadio, A.
2019
28 C p. 197-198
artikel
41 Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment Banerjee, Aditya
2019
28 C p. 60-63
artikel
42 Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study Barin, Laura
2019
28 C p. 17-25
artikel
43 Periodized home-based training: A new strategy to improve high intensity exercise therapy adherence in mildly affected patients with Multiple Sclerosis Keytsman, Charly
2019
28 C p. 91-97
artikel
44 Pilates for people with multiple sclerosis: A systematic review and meta-analysis Sánchez-Lastra, Miguel A.
2019
28 C p. 199-212
artikel
45 Pregnancy outcomes in Portuguese women with multiple sclerosis: The PREGNIMS study Novo, Ana
2019
28 C p. 172-176
artikel
46 Prevalence of asthma in multiple sclerosis: A United States population-based study Hill, Eddie
2019
28 C p. 69-74
artikel
47 Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis Rooney, Scott
2019
28 C p. 276-282
artikel
48 Progressive solitary sclerosis presented with diplopia: A case report Sahraian, Mohammad Ali
2019
28 C p. 129-131
artikel
49 Pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis. Case report and literature review Demerouti, Eftychia
2019
28 C p. 273-275
artikel
50 Risk of obstructive sleep apnea in multiple sclerosis: Frequency, clinical and radiological correlates Abdel Salam, Osama A.
2019
28 C p. 184-188
artikel
51 Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients Liu, Tianni
2019
28 C p. 177-183
artikel
52 Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation Martinelli, Vittorio
2019
28 C p. 57-59
artikel
53 The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis Li, Yu-Feng
2019
28 C p. 75-80
artikel
54 Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin Lanzillo, Roberta
2019
28 C p. 193-196
artikel
55 The role of vestibular evoked myogenic potentials in multiple sclerosis-related vertigo. A systematic review of the literature Di Stadio, Arianna
2019
28 C p. 159-164
artikel
56 Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients Narayan, Ram N.
2019
28 C p. 86-90
artikel
57 Unusual cortical involvement in aquaporin-4 antibody-positive patients: An analysis with double inversion recovery and phase-sensitive inversion recovery imaging Kim, Seung Woo
2019
28 C p. 283-285
artikel
58 Vitamin D and body mass index in Egyptian multiple sclerosis patients Zamzam, Dina
2019
28 C p. 313-316
artikel
                             58 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland